Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-04 4:00 pm Purchase | 2023-12-24 | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management, LLC | 4,870,931 15.100% | 1,904,391 (+64.20%) | Filing History |
| 2023-08-15 5:07 pm Sale | 2023-08-15 | 13D | LIFECORE BIOMEDICAL INC LFCR | Cove Street Capital LLC | 1,583,440 5.150% | -791,325 (-33.32%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock, Inc. BLK | 532,043 1.800% | -1,316,110 (-71.21%) | Filing History |
| 2023-06-30 2:46 pm Purchase | 2023-06-21 | 13G | LIFECORE BIOMEDICAL INC LFCR | Greenhaven Road Investment Management L.P. | 1,902,639 6.300% | 1,902,639 (New Position) | Filing History |
| 2023-06-28 4:32 pm Purchase | 2023-06-26 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 3,169,937 9.990% | 73,150 (+2.36%) | Filing History |
| 2023-03-16 4:15 pm Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. I | 4,926,795 16.600% | 464,285 (+10.40%) | Filing History |
| 2023-03-07 4:25 pm Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. | 5,387,830 17.900% | 461,035 (+9.36%) | Filing History |
| 2023-02-14 4:16 pm Sale | 2022-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | ISZO CAPITAL LP | 373,778 1.300% | -1,551,533 (-80.59%) | Filing History |
| 2023-02-10 2:42 pm Sale | 2023-02-14 | 13G | LIFECORE BIOMEDICAL INC LFCR | Dimensional Fund Advisors LP | 1,757,544 5.900% | -216,064 (-10.95%) | Filing History |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock, Inc. BLK | 1,848,153 6.200% | -98,305 (-5.05%) | Filing History |
| 2023-01-12 5:13 pm Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. | 4,926,795 16.600% | 2,362,271 (+92.11%) | Filing History |
| 2023-01-12 4:23 pm Purchase | 2023-01-12 | 13D | LIFECORE BIOMEDICAL INC LFCR | Cove Street Capital LLC | 2,374,765 7.890% | 578,401 (+32.20%) | Filing History |
| 2023-01-10 3:46 pm Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 3,096,787 9.990% | 1,341,626 (+76.44%) | Filing History |
| 2023-01-10 09:20 am Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management, LLC | 2,966,540 9.990% | 38,450 (+1.31%) | Filing History |
| 2022-12-02 4:15 pm Purchase | 2022-11-25 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. I | 4,462,510 14.800% | 884,805 (+24.73%) | Filing History |
| 2022-09-12 4:36 pm Purchase | 2022-08-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 1,755,161 6.000% | 1,755,161 (New Position) | Filing History |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | Russell Investments Group Ltd. | 208,428 0.710% | -2,383,126 (-91.96%) | Filing History |
| 2022-02-14 12:36 pm Purchase | 2021-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | ISZO CAPITAL LP | 1,925,311 6.500% | 1,925,311 (New Position) | Filing History |
| 2022-02-11 3:36 pm Purchase | 2021-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | Cove Street Capital LLC | 1,796,364 6.090% | 187,746 (+11.67%) | Filing History |
| 2022-02-10 08:22 am Sale | 2021-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | VANGUARD GROUP INC | 1,257,836 4.270% | -414,005 (-24.76%) | Filing History |